Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01436656
Title A Phase I Study of Oral LGX818 in Adult Patients With Advanced or Metastatic BRAF Mutant Melanoma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals
Indications

melanoma

colorectal cancer

Therapies

Encorafenib

Age Groups: senior | adult
Covered Countries FRA | ESP

Facility Status City State Zip Country Details
EDOG - Institut Claudius Regaud - PPDS Toulouse Haute-garonne 31059 Cedex 9 France Details
Institut Gustave Roussy Villejuif Val-de-marne 94805 France Details
Institut Gustave Roussy Villejuif 94805 France Details
National Cancer Center Hospital Chuo-ku Tokyo 104-0045 Japan Details
Hospital Clinic de Barcelona Badalona 08036 Spain Details
Hospital Universitario Vall d'Hebron - PPDS Barcelona 08035 Spain Details
Hospital Universitario HM Sanchinarro_CIOCC Madrid 28050 Spain Details
Kantonsspital Graubünden Chur Graubünden (DE) 07000 Switzerland Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field